Mesa Laboratories, Inc. (MLAB) Financials
MLAB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 427.7 million | ? |
| Dec. 31, 2025 | 434.8 million | 248.2 million |
| Sept. 30, 2025 | 430.4 million | 251.9 million |
| June 30, 2025 | 435.7 million | 263.2 million |
MLAB Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | ? | ? |
| Dec. 31, 2025 | 18.0 million | 3.4 million |
| Sept. 30, 2025 | 7.1 million | 3.8 million |
| June 30, 2025 | 884000 | 3.9 million |
MLAB Net Income
No data available :(
MLAB Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 26.9 million | - | - |
| Dec. 31, 2025 | 29.0 million | 98.3 million | 14.9 million |
| Sept. 30, 2025 | 20.4 million | 170.2 million | 15.6 million |
| June 30, 2025 | 21.3 million | 79.5 million | 16.4 million |
MLAB Shares Outstanding
MLAB Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | - | - | - |
| Dec. 31, 2025 | 732000 | 5.0 million | 28.8 million | 10.0 million |
| Sept. 30, 2025 | 1.1 million | 5.0 million | 27.6 million | 9.8 million |
| June 30, 2025 | 1.0 million | 5.0 million | 28.9 million | 10.9 million |
MLAB Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 63.7 million | 17.1 million |
| Dec. 31, 2025 | 65.1 million | 23.3 million |
| Sept. 30, 2025 | 60.7 million | 23.4 million |
| June 30, 2025 | 59.5 million | 27.0 million |
MLAB Revenue by Segment
MLAB
Price: $104.09
Dividend Yield: 0.63%
Forward Dividend Yield: 0.61%
Payout Ratio: -1.38%
Dividend Per Share: 0.64 USD
Earnings Per Share: 1.21 USD
P/E Ratio: 86.99
Exchange: NMS
Sector: Technology
Industry: Scientific & Technical Instruments
Country: United States
Volume: 46174
Ebitda: -7.6 millionMarket Capitalization: 581.5 million
Average Dividend Frequency: 4
Years Paying Dividends: 24
DGR10: 0.16%
DGR20: 2.71%